A randomised open label placebo study to evaluate the use of Solcogyn applied topically to the cervix in women referred for the assessment of cervical low grade intro-epithelial lesions

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN06133220

Enrollment

106

Registered

2003-09-12

Start date

2002-03-19

Completion date

Unknown

Last updated

2016-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dysplasia Urological and Genital Diseases Dysplasia

Interventions

1. Placebo (saline) 2. Solcogyn

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 106 women aged 20-50 attending the colposcopy clinic with cytological abnormalities showing borderline or mild changes and who also have a cervical ectopy.

Exclusion criteria

Exclusion criteria: Not provided at time of registration

Design outcomes

Primary

Measure	Time frame
Increased number of patients returning to normal cytology after six months of treatment.	—

Secondary

Measure	Time frame
Not provided at time of registration	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026